Earnings Call · Q4 FY2023·2024-03-27

Q4 23EPS +6.67%·Rev n/aQ3 23EPS 0.00%·Rev n/aQ2 23EPS +27.78%·Rev n/aQ1 23EPS -6.25%·Rev n/a⚠ consensus missing

CRESCENT BIOPHARMA, INC. CBIO

Christian Dinneen-Long — Unknown - likely executive or senior management

Harout Semerjian — Chief Executive Officer

Edwin Rock — Unknown - likely executive or senior management

Bruce Johnson — Commercial or Business Executive

Brian Hahn — Finance Executive

+11.6%1d on move date+10.7% vs SPY3d+6.7%5d−2.8%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CBIO calls or request research access.

More CBIO calls Browse calls Request research access